19 insiders have filed at AORT since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Mackin James P | President & CEO | 947.3k | 1.905% | 22 sells $13.9M | |
| Davis John E | Chief Commercial Officer | 230.8k | 0.464% | 23 sells $3.2M | |
| Berry Lance A | EVP, COO, CFO & Treasurer | 210.8k | 0.424% | 6 sells $994k | |
| Holloway Jean F | SVP, General Counsel | 185.1k | 0.372% | 38 sells $6.1M | |
| Bevevino Daniel J | Director | 150.1k | 0.302% | ||
| Ackerman Thomas F | Director | 149.9k | 0.301% | ||
| Horton Amy | VP, Chief Accounting Officer | 139.1k | 0.28% | 24 sells $2.2M | |
| Salveson Jon W | Director | 129.8k | 0.261% | ||
| Bullock James | Director | 68.6k | 0.138% | ||
| Stanton Marshall S. | SVP, Clinical & Md Affair | 60.1k | 0.121% | 32 sells $6.0M | |
| Burbank Jeffrey H | Director | 53.8k | 0.108% | ||
| Borgstrom Marna P | Director | 49.1k | 0.099% | ||
| Maney Rochelle L. | VP, Quality | 46.5k | 0.094% | 5 sells $84k | |
| Getz Matthew A | VP, Human Resources | 34.1k | 0.069% | 9 sells $445k | |
| Green Andrew M | VP Regulatory | 33.5k | 0.067% | 7 sells $416k | |
| Semedo Anthony B. | Director | 33.1k | 0.066% | 2 buys $53k | 2 sells $317k |
| Hoff Elizabeth A | Director | 27.2k | 0.055% | 1 sells $189k | |
| Tyrs Florian | VP, Global Operations | 25.7k | 0.052% | 3 sells $30k | |
| Thomson Robert C | VP Research & Development | 13.3k | 0.027% |
Full register at boothcheck.com/insiders/AORT. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.